FIXX News and Press, Homology Medicines Inc. From 04/19/21

Homology Medicines Inc. (NASDAQ:FIXX) traded at a new 52-week low today of $6.50. Approximately 857,000 shares have changed hands today, as compared to an average 30-day volume of 810,000 shares. Potential upside of 2.5% exists for Homology Medicines Inc., based on a current level of $6....

- Data From Company’s PKU and Hunter Syndrome Gene Therapy Programs Featured in Presentations - BEDFORD, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today two presentations highlighti...

Homology Medicines Inc. (NASDAQ:FIXX) traded at a new 52-week low today of $6.77. This new low was reached on approximately average trading volume as 857,000 shares traded hands, while the average 30-day volume is approximately 717,000 shares. In the past 52 weeks, Homology Medicines Inc...

Homology Medicines (FIXX) announces the promotion of Tim Kelly to chief operating officer from previously held role of the company's chief technical operating officer.The change in effective immediately.Prior to joining Homology Medicines, Kelly has held leadership positions at Shire (SH...

- Built Internal GMP Commercial Process and Manufacturing Platform and Scaled HEK293 Suspension System to 2,000L Under His Leadership - BEDFORD, Mass., April 12, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today tha...

Gainers: Bonso Electronics International (BNSO) +36%.SOS (SOS) +29%.Ouster (OUST) +29%.ION Geophysical (IO) +22%.Odonate Therapeutics (ODT) +20%.Titan Medical (TMDI) +16%.Cocrystal Pharma (COCP) +15%.Ocugen (OCGN) +15%.Pintec Technology (PT) +13%.Frequency Therapeutics (FREQ) +...

Shares of Homology Medicines (NASDAQ: FIXX) were sinking 17.8% lower as of 12:01 p.m. EDT on Wednesday. The decline came after the company announced the pricing of its latest public stock offering. Biotech stocks usually fall after public stock offerings are announced. The i...

Gainers: Odonate Therapeutics (ODT) +34%, Ocugen (OCGN) +24%, Titan Medical (TMDI) +15%, Frequency Therapeutics (FREQ) +14, 9 Meters Biopharma (NMTR) +10%%.Losers: FibroGen (FGEN) -39%, Homology Medicines (FIXX) -18%, Galectin Therap...

FibroGen (FGEN) -29% after FDA AdCom to review FibroGen's roxadustat application on July 15.Galectin Therapeutics (GALT) -9%.Homology Medicines (FIXX) -10% after proposes $50M capital raise.The GEO Group (GEO) -10% after suspends dividend to pay down debt; will e...

Gainers: [[AKBA]] +12.1%. [[SYBX]] +7.1%. [[ARDX]] +5.2%. [[ODT]] +4.9%. [[BYND]] +4.2%.Losers: [[FGEN]] -29.2%. [[FIXX]] -10.2%. [[MAXN]] -6.8%. [[IONS]] -5.8%. [[OM]] -5.4%. For further details see: AKBA, SYBX, FGEN and FIXX among after-hours movers